Patent · US Active

Sulfinylpyridines and their use in the treatment of cancer

US11208384B2 · kind B2 · utility

0Cited by

5References

17Claims

0Family size

Assignee

OBLIQUE THERAPEUTICS AB · SE

Inventors

Benjamin Pelcman · Stockholm, SE
Owe Orwar · Hagfors, SE
William Stafford · Älta, SE
Kjell Andersson · Kungsbacka, SE

Key dates

Filing date	Feb 7, 2018
Grant date	Dec 28, 2021
Priority date	—
Expiry date	Feb 7, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3, R4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.